scholarly article | Q13442814 |
P50 | author | Olivier Schwartz | Q56373580 |
Jean-Pierre Vartanian | Q60728893 | ||
Renaud Mahieux | Q60975730 | ||
P2093 | author name string | Simon Wain-Hobson | |
Michel Henry | |||
Frédéric Delebecque | |||
Rodolphe Suspène | |||
P433 | issue | Pt 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
Human T-lymphotropic virus 1 | Q1280388 | ||
T-cell leukemia | Q7667895 | ||
P304 | page(s) | 2489-2494 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Journal of General Virology | Q6295245 |
P1476 | title | Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases | |
P478 | volume | 86 |
Q38949554 | A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage |
Q40142288 | A putative antiviral role of plant cytidine deaminases |
Q21131084 | AID and APOBECs span the gap between innate and adaptive immunity |
Q24634922 | APOBEC1-mediated editing and attenuation of herpes simplex virus 1 DNA indicate that neurons have an antiviral role during herpes simplex encephalitis |
Q28081195 | APOBEC3 Interference during Replication of Viral Genomes |
Q37080617 | APOBEC3 proteins and reverse transcription |
Q38949590 | APOBEC3A catabolism of electroporated plasmid DNA in mouse muscle. |
Q24310242 | APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1 |
Q40237040 | APOBEC3G and HIV-1: strike and counterstrike |
Q46226044 | APOBEC3G and HIV-1: strike and counterstrike |
Q39704609 | APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo |
Q28754989 | APOBEC3G: an intracellular centurion |
Q38394187 | APOBECs and virus restriction |
Q38006906 | Apolipoprotein B mRNA-editing, catalytic polypeptide cytidine deaminases and retroviral restriction |
Q36845680 | Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection |
Q55239314 | Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. |
Q37198681 | Current topics in prevention of human T-cell leukemia virus type i infection: NF-kappa B inhibitors and APOBEC3. |
Q35914312 | Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation |
Q36845658 | DNA deamination in immunity: AID in the context of its APOBEC relatives. |
Q92675146 | Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure |
Q42041441 | Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution |
Q37099784 | Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif. |
Q95597741 | Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2 |
Q34137458 | Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions |
Q39118027 | Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins |
Q24305160 | Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo |
Q33677823 | Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3. |
Q34974240 | Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death |
Q24625056 | Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity |
Q35850930 | Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation |
Q92703239 | Interplay between Intrinsic and Innate Immunity during HIV Infection |
Q39976644 | Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs |
Q35131366 | Lack of association between intact/deletion polymorphisms of the APOBEC3B gene and HIV-1 risk |
Q33594457 | Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis |
Q26823568 | Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all |
Q31036522 | Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response |
Q37091342 | Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity |
Q37140497 | Powerful mutators lurking in the genome |
Q35669808 | Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid |
Q60046078 | Restriction Factors: From Intrinsic Viral Restriction to Shaping Cellular Immunity Against HIV-1 |
Q58866812 | Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity |
Q38132389 | The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators |
Q37265843 | The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution. |
Q55363233 | The rabbit as an orthologous small animal model for APOBEC3A oncogenesis. |
Q35192821 | The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B. |
Q41812539 | The role of cytidine deaminases on innate immune responses against human viral infections. |
Q34539110 | Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C. |
Search more.